| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ANA.410360505 |
| P698 | PubMed publication ID | 7979217 |
| P50 | author | Andreas von Deimling | Q40381084 |
| P2093 | author name string | Louis DN | |
| Benedict WF | |||
| Henson JW | |||
| Fassbender F | |||
| Yandell DW | |||
| Xu HJ | |||
| Correa KM | |||
| Schnitker BL | |||
| P433 | issue | 5 | |
| P921 | main subject | retinoblastoma | Q500695 |
| P304 | page(s) | 714-721 | |
| P577 | publication date | 1994-11-01 | |
| P1433 | published in | Annals of Neurology | Q564414 |
| P1476 | title | The retinoblastoma gene is involved in malignant progression of astrocytomas | |
| P478 | volume | 36 |
| Q33891429 | A graphic method for identification of novel glioma related genes. |
| Q52537791 | A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. |
| Q40372189 | A tiger behind many doors: multiple genetic pathways to malignant glioma |
| Q40167515 | Altered structure and deregulated expression of the tumor suppressor gene retinoblastoma (RB1) in human brain tumors |
| Q48611673 | Analyses of human gliomas by restriction landmark genomic scanning |
| Q48035681 | Analysis of chromosome abnormalities by comparative genomic hybridization in malignant peripheral primitive neuroectodermal tumor of the ovary |
| Q48567039 | Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation |
| Q33532647 | Automated network analysis identifies core pathways in glioblastoma |
| Q48482815 | BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study |
| Q35753196 | CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations |
| Q55473770 | Cell cycle regulators (p21, p53, pRb) in oligodendrocytic tumors: a study by novel tumor microarray technique. |
| Q42021790 | Characterization of six tumor suppressor genes and microsatellite instability in hepatocellular carcinoma in southern African blacks |
| Q35634253 | Clinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtype |
| Q42118637 | Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1). |
| Q38302408 | CpG island methylation status and mutation analysis of the RB1 gene essential promoter region and protein-binding pocket domain in nervous system tumours |
| Q24630927 | Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century |
| Q34283491 | Delivery of cell cycle genes to block astrocytoma growth |
| Q40470907 | Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization. |
| Q26829873 | Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets |
| Q37504261 | Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytoma |
| Q35764748 | Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications |
| Q35846538 | Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737-Mediated Cell Death in Malignant Human Glioma Cell Lines |
| Q33253913 | Downregulation of RUNX3 and TES by hypermethylation in glioblastoma |
| Q34787109 | Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome |
| Q35914897 | Emerging insights into the molecular and cellular basis of glioblastoma |
| Q37003757 | Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study |
| Q45613688 | Evaluation of miR-362 Expression in Astrocytoma of Human Brain Tumors |
| Q48428399 | Evaluation of molecular genetic alterations associated with tumor progression in a case of gliomatosis cerebri |
| Q35117832 | Genetic alterations of human brain tumors as molecular prognostic factors |
| Q40543091 | Genetic alterations of the NRP/B gene are associated with human brain tumors |
| Q37838362 | Genetic modeling of gliomas in mice: new tools to tackle old problems |
| Q37348716 | Genetically engineered mouse models of brain cancer and the promise of preclinical testing |
| Q48633313 | Genomic alterations in human glioma cell lines detected by restriction landmark genomic scanning |
| Q37946264 | Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights |
| Q37602543 | Glioblastoma Multiforme Oncogenomics and Signaling Pathways |
| Q34366431 | Glioma models |
| Q24297641 | HAUSP, a novel deubiquitinase for Rb - MDM2 the critical regulator |
| Q36645878 | High-resolution genome-wide allelotype analysis identifies loss of chromosome 14q as a recurrent genetic alteration in astrocytic tumours |
| Q55474476 | Identification of extensive genomic loss and gain by comparative genomic hybridisation in malignant astrocytoma in children and young adults. |
| Q40785730 | Identification of uncommon chromosomal aberrations in the neuroglioma cell line H4 by spectral karyotyping |
| Q26862847 | In vivo models of primary brain tumors: pitfalls and perspectives |
| Q35440540 | Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System. |
| Q47193299 | Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma. |
| Q53442919 | Loss of retinoblastoma gene function and heterozygosity at the RB locus in renal cortical neoplasms. |
| Q33913068 | Low penetrance of retinoblastoma for p.V654L mutation of the RB1 gene |
| Q48422991 | Malignant glioma: should chemotherapy be overthrown by experimental treatments? |
| Q34002994 | Mesenchymal migration as a therapeutic target in glioblastoma |
| Q38525862 | Missense mutation of the MET gene detected in human glioma |
| Q41626535 | Molecular aspects of neuro-oncology |
| Q27001295 | Molecular biology of gliomas: present and future challenges |
| Q24678750 | Molecular genetic analysis of giant cell glioblastomas |
| Q34478051 | Molecular genetics of pineal region neoplasms |
| Q36226724 | Molecular mechanisms in gliomagenesis |
| Q41687849 | Molecular neuropathology of astrocytic brain tumors |
| Q40961534 | Molecular pathways in the formation of gliomas. |
| Q37858944 | Molecular subclassification of diffuse gliomas: seeing order in the chaos |
| Q41903586 | Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours |
| Q35795458 | NF2 gene analysis distinguishes hemangiopericytoma from meningioma. |
| Q30426593 | P16 deletion and mutation analysis in human brain tumors |
| Q37640890 | PCNA and Ki-67 labelling indices in pre-irradiated and post-irradiated astrocytomas: a comparative immunohistochemical analysis for evaluation of proliferative activity |
| Q55474611 | Promoter hypermethylation of the RB1 gene in glioblastomas. |
| Q48657987 | Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma |
| Q48262753 | Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors |
| Q37736255 | Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma |
| Q30998003 | Techniques to assess the proliferative potential of brain tumors |
| Q30357109 | The N Terminus of the Retinoblastoma Protein Inhibits DNA Replication via a Bipartite Mechanism Disrupted in Partially Penetrant Retinoblastomas. |
| Q24657924 | The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo |
| Q37220909 | The molecular genetics of astrocytomas: current understanding and future applications |
| Q28118814 | The neural progenitor-restricted isoform of the MARK4 gene in 19q13.2 is upregulated in human gliomas and overexpressed in a subset of glioblastoma cell lines |
| Q33921072 | The pathobiology of glioma tumors |
| Q41731369 | The role of transforming growth factor beta in glioma progression |
| Q55478756 | Transforming growth factor beta as a potential tumor progression factor among hyperdiploid glioblastoma cultures: evidence for the role of platelet-derived growth factor. |
| Q32034495 | Trilateral retinoblastoma: insights into histogenesis and management |
| Q34278098 | Tumor suppression by a severely truncated species of retinoblastoma protein |
| Q30661179 | Voting-based cancer module identification by combining topological and data-driven properties |
Search more.